Skip to content

Evaluating the efficacy of Losartan ointment in wound healing

Evaluating the efficacy of Losartan ointment (an Angiotensin II Type I Receptor) in wound healing and preventing hypertrophic scars and keloids formation (useful in the injured military soldiers )

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201205049601N1
Enrollment
24
Registered
2020-12-16
Start date
2021-02-03
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wound healing and preventing hypertrophic scars and keloids formation. Hypertrophic scar

Interventions

Intervention 1: Intervention group: First a patient's scar will be categorized into two similar groups (Left and side). A Part of the scar selected randomly will be treated with Losartan ointment. The

Sponsors

Artesh University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: The patient’s scar length should be more than 10 centimeter, or they should have several scars with total length of 10 centimeter. The patient’s age should be between 18 to 50 years old.

Exclusion criteria

Exclusion criteria: The patients who did not regularly consume ointments will be excluded. The patients who are pregnant, consume antihypertensive drugs, or have history of cancer, allergy and bleeding or discharge at scar site will be excluded.

Design outcomes

Primary

MeasureTime frame
Scare assessment, Vancouver Scar Scale (VSS) assesses 4 variables: vascularity, height/thickness, pliability, and pigmentation. The overall score is between 0 to 13. Timepoint: Three and six months after ointment administration. Method of measurement: The evaluators are doctors who will use VSS or Vancouver scar scale to rate the scar change. Vancouver Scar Scale (VSS) assesses 4 variables: vascularity, height/thickness, pliability, and pigmentation. The overall score is between 0 to 13.

Secondary

MeasureTime frame
Itching is an irritating sensation of the skin which will be measured by the Visual Analogue Scale. Timepoint: Three and six months after ointment administration. Method of measurement: The evaluators are doctors and will be measured by the Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Khodai

Artesh University of Medical Sciences

khodaibehzad@gmail.com+98 21 7769 4460

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026